Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The active ingredient that makes magic mushrooms so magic—the psychedelic drug psilocybin—is one step closer to becoming a legal treatment for difficult
Investorideas.com a global investor news source covering psilocybin and psychedelic health and wellness stocks releases a special news report featuring Kaya Holdings, Inc. . As psilocybin and other...
Pioneers and Innovators in Psilocybin Treatments (OTCQB: KAYS) (NASDAQ: CMPS) (NYSE: CYBN) (OTC: MSSTF)
With MDMA on track to gain United States Food and Drug Administration (FDA) approval for the treatment of post-traumatic stress disorder (PTSD) in 2024, Big...
Researchers mined an old drug forum and fed the entries to an AI. The result could augur a new class of psychedelic-based antidepressants.